ESC 365 - Cardiovascular risk assessment and effects on behavior in Switzerland: the CardioTest.

EAPC Premium Access

Cardiovascular risk assessment and effects on behavior in Switzerland: the CardioTest.

Session: A new approach in CVD risk management, the role of pharmacists

Topic: Public health and health policy

Speaker: Professor O. Pfister (Basel, CH)

Event: EuroPrevent 2017

Congress Presentation

Add to my library

About the speaker

Professor Otmar Pfister

University Hospital Basel, Basel (Switzerland)

1 presentation

0 follower

3 more presentations in this session

The effectiveness of pharmacist interventions on cardiovascular risk.

Speaker: Professor R. Tsuyuki (Edmonton, CA)

Check-up your heart health at Swedish pharmacies.

Speaker: Mrs M. Norelius (Lidingo, SE)

Do Greek pharmacists have a role in CVD prevention? A pharmacy-led weight management Programme.

Speaker: Doctor A. Peletidi (Kingston Upon Thames, GB) Doctor R. Kayyali (Kingston Upon Thames, GB)

Access the full session

A new approach in CVD risk management, the role of pharmacists

Speakers: Professor O. Pfister, Professor R. Tsuyuki, Mrs M. Norelius, Doctor A. Peletidi, Doctor R. Kayyali

About the event

EuroPrevent 2017

6 April - 8 April 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources